foxo4 dri human trial senolytic Tools to eliminate senescent cells The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI 10mg Senescence Pathway Research Peptide Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOX04 DRI (10mg) Nordsci Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine
Pay in 4 interest-free payments of $5.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




